APA

Herrlinger K. R., Diculescu M., Fellermann K., Hartmann H., Howaldt S., Nikolov R., Petrov A., Reindl W., Otte J. M., Stoynov S., Strauch U., Sturm A., Voiosu R., Ammendola A., Dietrich B., Hentsch B. & Stange E. F. (20140404). Efficacy, safety and tolerability of vidofludimus in patients with inflammatory bowel disease: the ENTRANCE study. : Journal of Crohn's & colitis.

Chicago

Herrlinger K R, Diculescu M, Fellermann K, Hartmann H, Howaldt S, Nikolov R, Petrov A, Reindl W, Otte J M, Stoynov S, Strauch U, Sturm A, Voiosu R, Ammendola A, Dietrich B, Hentsch B and Stange E F. 20140404. Efficacy, safety and tolerability of vidofludimus in patients with inflammatory bowel disease: the ENTRANCE study. : Journal of Crohn's & colitis.

Harvard

Herrlinger K. R., Diculescu M., Fellermann K., Hartmann H., Howaldt S., Nikolov R., Petrov A., Reindl W., Otte J. M., Stoynov S., Strauch U., Sturm A., Voiosu R., Ammendola A., Dietrich B., Hentsch B. and Stange E. F. (20140404). Efficacy, safety and tolerability of vidofludimus in patients with inflammatory bowel disease: the ENTRANCE study. : Journal of Crohn's & colitis.

MLA

Herrlinger K R, Diculescu M, Fellermann K, Hartmann H, Howaldt S, Nikolov R, Petrov A, Reindl W, Otte J M, Stoynov S, Strauch U, Sturm A, Voiosu R, Ammendola A, Dietrich B, Hentsch B and Stange E F. Efficacy, safety and tolerability of vidofludimus in patients with inflammatory bowel disease: the ENTRANCE study. : Journal of Crohn's & colitis. 20140404.